Minimally invasive procedure for skeletal metastases may improve function, relieve pain
SAN DIEGO — Minimally invasive ablation, balloon osteoplasty, cement reinforcement and internal fixation may improve pain, functional status and quality of life in patients with skeletal metastases, according to results presented here.
Francis Y. Lee, MD, PhD, and colleagues preoperatively and postoperatively assessed pain outcomes and functional improvements among patients with painful osteolytic skeletal metastases in the periacetabular region who underwent minimally invasive ablation, balloon osteoplasty, cement reinforcement and internal fixation (AORIF) with cannulated screws. Researchers also assessed infection, transfusion requirements, length of stay, 30-day readmission, subsequent acetabular fractures and requirement for conversion to total hip arthroplasty.
“When we assessed pain and functional outcomes at 2 weeks, 25 ambulatory patients remained ambulatory with less pain and more function,” Lee, the Wayne O. Southwick professor of musculoskeletal oncology at Yale Orthopedics and Rehabilitation, Yale School of Medicine, told Healio Orthopedics about results presented at the American Academy of Orthopaedic Surgeons Annual Meeting.
Lee added 14 of the 17 patients who were non-ambulatory became ambulatory with use of a cane or walker. Results showed no cases of surgical site infection, subsequent conversion into THA, readmission or delayed oncologic care related to AORIF.
“By doing this minimal percutaneous procedure, complications associated with open surgeries, such as infection, delayed wound healing, prolonged hospitalization and prolonged rehabilitation, can be avoided and, therefore, patients can have life-saving chemotherapy immediately after AORIF,” Lee said.